Reducing HSV-2 Morbidity and Mortality: Routine Serologic Screening Still Not the Best Answer.

Pearlman, Mark D

Pearlman, Mark D.

Pearlman MD; Department of Obstetrics and Gynecology and Department of Surgery, University of Michigan Health System, Ann Arbor.

JAMA ; 329(6): 469-471, 2023 02 14.

Article in English | MEDLINE | ID: covidwho-2275996

Subject(s)

Herpes Genitalis; Herpes Simplex; Humans; Antibodies, Viral; Blood Coagulation Tests; Herpes Genitalis/diagnosis; Herpes Genitalis/mortality; Herpes Simplex/diagnosis; Herpes Simplex/mortality; Herpesvirus 2, Human; Morbidity; Serologic Tests

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Herpes Genitalis / Herpes Simplex Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: JAMA Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google